Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3681 | 1932 | 38.7 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
124 | 3 | PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION | 67777 |
332 | 2 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN | 18089 |
3681 | 1 | MPTP//MPP//1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | 1932 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MPTP | authKW | 1488433 | 20% | 24% | 389 |
2 | MPP | authKW | 415082 | 6% | 22% | 120 |
3 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | authKW | 370190 | 4% | 29% | 81 |
4 | 1 METHYL 4 PHENYLPYRIDINIUM | authKW | 274297 | 3% | 35% | 50 |
5 | 1 METHYL 4 PHENYLPYRIDINIUM ION MPP | authKW | 224801 | 1% | 68% | 21 |
6 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE MPTP | authKW | 190343 | 2% | 38% | 32 |
7 | 1 METHYL 4 PHENYLPYRIDINIUM ION | authKW | 162054 | 1% | 49% | 21 |
8 | MPTP 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | authKW | 86706 | 1% | 37% | 15 |
9 | PARKINSONS DISEASE | authKW | 86434 | 21% | 1% | 406 |
10 | ALTERNAT MED EXPT THER EUT | address | 70391 | 0% | 64% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 18571 | 57% | 0% | 1092 |
2 | Pharmacology & Pharmacy | 2840 | 24% | 0% | 464 |
3 | Toxicology | 822 | 7% | 0% | 133 |
4 | Biochemistry & Molecular Biology | 765 | 20% | 0% | 392 |
5 | Clinical Neurology | 549 | 9% | 0% | 170 |
6 | Medicine, Research & Experimental | 272 | 6% | 0% | 108 |
7 | Biophysics | 214 | 5% | 0% | 95 |
8 | Chemistry, Medicinal | 135 | 3% | 0% | 63 |
9 | Behavioral Sciences | 97 | 2% | 0% | 40 |
10 | Pathology | 54 | 2% | 0% | 43 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALTERNAT MED EXPT THER EUT | 70391 | 0% | 64% | 7 |
2 | DRUG METAB THER EUT | 33458 | 0% | 35% | 6 |
3 | GEORGE MARYLOU BOONE PARKINSONS DIS MOVEMENT | 31607 | 0% | 100% | 2 |
4 | NEUROL SERV WARREN 408 | 31607 | 0% | 100% | 2 |
5 | BEHAV NEUROSCI PATHOL | 24686 | 0% | 31% | 5 |
6 | BIOCHEM MOL BIOL NEUROL | 21070 | 0% | 67% | 2 |
7 | HARVEY W PETERS STUDY PARKINSONS DIS | 21070 | 0% | 67% | 2 |
8 | MEF FISIOL | 21070 | 0% | 67% | 2 |
9 | MED DENT NEUROBIOL ANAT | 17775 | 0% | 38% | 3 |
10 | PHARMACEUT SCI MED | 15989 | 1% | 7% | 15 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROSCIENCE LETTERS | 9980 | 7% | 0% | 141 |
2 | BRAIN RESEARCH | 8937 | 9% | 0% | 165 |
3 | JOURNAL OF NEUROCHEMISTRY | 7779 | 5% | 0% | 102 |
4 | NEURODEGENERATION | 6078 | 0% | 5% | 8 |
5 | JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION | 5697 | 0% | 4% | 9 |
6 | NEUROCHEMISTRY INTERNATIONAL | 5175 | 2% | 1% | 42 |
7 | JOURNAL OF NEURAL TRANSMISSION | 4428 | 2% | 1% | 34 |
8 | LIFE SCIENCES | 4076 | 4% | 0% | 73 |
9 | NEUROTOXICOLOGY | 3705 | 1% | 1% | 28 |
10 | RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE | 3578 | 0% | 3% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SAYRE, LM , (1989) BIOCHEMICAL-MECHANISM OF ACTION OF THE DOPAMINERGIC NEUROTOXIN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP).TOXICOLOGY LETTERS. VOL. 48. ISSUE 2. P. 121-149 | 190 | 89% | 91 |
2 | GERLACH, M , RIEDERER, P , PRZUNTEK, H , YOUDIM, MBH , (1991) MPTP MECHANISMS OF NEUROTOXICITY AND THEIR IMPLICATIONS FOR PARKINSONS-DISEASE.EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION. VOL. 208. ISSUE 4. P. 273-286 | 107 | 88% | 197 |
3 | SEDELIS, M , SCHWARTING, RKW , HUSTON, JP , (2001) BEHAVIORAL PHENOTYPING OF THE MPTP MOUSE MODEL OF PARKINSON'S DISEASE.BEHAVIOURAL BRAIN RESEARCH. VOL. 125. ISSUE 1-2. P. 109-125 | 81 | 63% | 207 |
4 | JAKOWEC, MW , PETZINGER, GM , (2004) 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED MODEL OF PARKINSON'S DISEASE, WITH EMPHASIS ON MICE AND NONHUMAN PRIMATES.COMPARATIVE MEDICINE. VOL. 54. ISSUE 5. P. 497 -513 | 104 | 50% | 55 |
5 | TIPTON, KF , SINGER, TP , (1993) ADVANCES IN OUR UNDERSTANDING OF THE MECHANISMS OF THE NEUROTOXICITY OF MPTP AND RELATED-COMPOUNDS.JOURNAL OF NEUROCHEMISTRY. VOL. 61. ISSUE 4. P. 1191-1206 | 76 | 66% | 452 |
6 | MARET, G , TESTA, B , JENNER, P , ELTAYAR, N , CARRUPT, PA , (1990) THE MPTP STORY - MAO ACTIVATES TETRAHYDROPYRIDINE DERIVATIVES TO TOXINS CAUSING PARKINSONISM.DRUG METABOLISM REVIEWS. VOL. 22. ISSUE 4. P. 291-332 | 107 | 74% | 42 |
7 | MEREDITH, GE , RADEMACHER, DJ , (2011) MPTP MOUSE MODELS OF PARKINSON'S DISEASE: AN UPDATE.JOURNAL OF PARKINSONS DISEASE. VOL. 1. ISSUE 1. P. 19-33 | 73 | 49% | 33 |
8 | PIFL, C , SCHINGNITZ, G , HORNYKIEWICZ, O , (1991) EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE ON THE REGIONAL DISTRIBUTION OF BRAIN MONOAMINES IN THE RHESUS-MONKEY.NEUROSCIENCE. VOL. 44. ISSUE 3. P. 591-605 | 65 | 81% | 136 |
9 | KINEMUCHI, H , FOWLER, CJ , TIPTON, KF , (1987) THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) AND ITS RELEVANCE TO PARKINSONS-DISEASE.NEUROCHEMISTRY INTERNATIONAL. VOL. 11. ISSUE 4. P. 359-373 | 90 | 76% | 55 |
10 | LANGSTON, JW , IRWIN, I , (1986) MPTP - CURRENT CONCEPTS AND CONTROVERSIES.CLINICAL NEUROPHARMACOLOGY. VOL. 9. ISSUE 6. P. 485-507 | 64 | 90% | 190 |
Classes with closest relation at Level 1 |